MammaTyper Test Able to Identify Women at Low Risk of Breast Cancer Spreading, Studies Show

MammaTyper Test Able to Identify Women at Low Risk of Breast Cancer Spreading, Studies Show
BioNTech Diagnostics’ MammaTyper test lets doctors determine the type of breast cancer a woman has and identify patients at low risk of having their cancer spread. The company discussed the diagnostic test’s effectiveness at the Breast Cancer Symposium in San Antonio in December 2017. MammaTyper measures levels of several breast cancer biomarkers in messenger RNA, a molecule that is

Knowledge is power when living with breast cancer.

Get access to the web’s leading Breast Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *